OTC Markets EXMKT - Delayed Quote USD

Aridis Pharmaceuticals, Inc. (ARDS)

0.0001
0.0000
(0.00%)
As of May 14 at 1:12:45 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
19,602
0
0
0
Operating Expense
20,485
29,993
42,711
22,401
Operating Income
-883
-29,993
-42,711
-22,401
Net Non Operating Interest Income Expense
177
-121
-245
77
Other Income Expense
-436
-257
763
-9
Pretax Income
-1,142
-30,371
-42,193
-22,333
Net Income Common Stockholders
-1,142
-30,371
-46,320
-22,333
Diluted NI Available to Com Stockholders
-1,142
-30,371
-46,320
-22,333
Basic EPS
-0.12
-1.62
-3.85
-2.44
Diluted EPS
-0.16
-1.62
-3.85
-2.44
Basic Average Shares
32,172.7380
18,777.3350
12,291.6000
9,168.7440
Diluted Average Shares
40,885.3660
18,777.3350
12,291.6000
9,168.7440
Total Operating Income as Reported
-883
-29,993
-42,711
-22,401
Total Expenses
20,485
29,993
42,711
22,401
Net Income from Continuing & Discontinued Operation
-1,142
-30,371
-42,193
-22,333
Normalized Income
-1,142
-30,371
-42,915
-22,333
Interest Income
--
--
--
77
Net Interest Income
177
-121
-245
77
EBIT
-883
-29,993
-42,711
-22,401
EBITDA
-574
-29,506
-42,276
-22,064
Reconciled Depreciation
309
487
435
337
Net Income from Continuing Operation Net Minority Interest
-1,142
-30,371
-42,193
-22,333
Total Unusual Items Excluding Goodwill
0
0
722
0
Total Unusual Items
0
0
722
0
Normalized EBITDA
-574
-29,506
-42,998
-22,064
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
12/31/2020 - 8/14/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BIOVz.XC
 
LIXT Lixte Biotechnology Holdings, Inc.
1.3400
-8.22%
 
SCPS Scopus BioPharma Inc.
0.0003
0.00%
 
RGBPP Regen BioPharma, Inc.
0.0526
0.00%
 
AWKNF Awakn Life Sciences Corp.
0.0650
0.00%
 
ELOX Eloxx Pharmaceuticals, Inc.
0.0001
0.00%
 
RVMDW Revolution Medicines, Inc.
0.2000
+25.00%
 
MOLN Molecular Partners AG
3.8600
-1.28%
 
OTLC Oncotelic Therapeutics, Inc.
0.0511
-12.50%
 
SNPX Synaptogenix, Inc.
2.2382
-10.47%